Cargando…

Combination of Azathioprine and Aminosalicylate Treatment Prevent Risk of Cardiovascular Disease in Women with Ulcerative Colitis by Reducing Inflammation

BACKGROUND: Ulcerative colitis (UC) is a chronic inflammatory bowel disease with involvement of the immune system. Chronic inflammatory diseases have been associated with increased risk of cardiovascular disease (CVD) but few studies have assessed this risk in patients with UC and the influence of d...

Descripción completa

Detalles Bibliográficos
Autores principales:	dos Santos, Lana Claudinez, Costa, Aline Villela, Lopes, Lorrayne Gonçalves, Leonel, Alda Jusceline, Aguilar, Edenil Costa, de Lourdes Meirelles Noviello, Maria, de Lourdes de Abreu Ferrari, Maria, Alvarez-Leite, Jacqueline I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2015
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532194/ https://www.ncbi.nlm.nih.gov/pubmed/26252649 http://dx.doi.org/10.12659/MSM.893865

Ejemplares similares

New Genetic Biomarkers Predicting Azathioprine Blood Concentrations in Combination Therapy with 5-Aminosalicylic Acid
por: Uchiyama, Kazuhiko, et al.
Publicado: (2014)

Azathioprine, Mercaptopurine, and 5-Aminosalicylic Acid Affect the Growth of IBD-Associated Campylobacter Species and Other Enteric Microbes
por: Liu, Fang, et al.
Publicado: (2017)

The combination of high-fat diet-induced obesity and chronic ulcerative colitis reciprocally exacerbates adipose tissue and colon inflammation
por: Teixeira, Lílian G, et al.
Publicado: (2011)

5-Aminosalicylic acid aggravates colitis mimicking exacerbation of ulcerative colitis
por: Miyoshi, Jun, et al.
Publicado: (2018)

Patient Preference and Adherence to Aminosalicylates for the Treatment of Ulcerative Colitis
por: Tripathi, Kartikeya, et al.
Publicado: (2021)

Maintaining infliximab induced clinical remission with azathioprine and 5-aminosalicylates in acute severe steroid-refractory ulcerative colitis has lower cost and high efficacy (MIRACLE): a multicenter study
por: Mahajan, Ramit, et al.
Publicado: (2022)

Medical Management of Ulcerative Colitis with a Specific Focus on 5-Aminosalicylates
por: Freeman, Hugh James
Publicado: (2012)

The Synergistic Effects of 5-Aminosalicylic Acid and Vorinostat in the Treatment of Ulcerative Colitis
por: He, Long, et al.
Publicado: (2021)

Significance of 5-Aminosalicylic Acid Intolerance in the Clinical Management of Ulcerative Colitis
por: Mikami, Yohei, et al.
Publicado: (2023)

Alopecia Universalis Associated with Ulcerative Colitis and The Role of Azathioprine
por: Shohdy, Kyrillus S, et al.
Publicado: (2018)

Use of Azathioprine in Ulcerative Colitis: A Comprehensive Review
por: Mallick, Bipadabhanjan, et al.
Publicado: (2022)

5-Aminosalicylic Acid Alters the Gut Bacterial Microbiota in Patients With Ulcerative Colitis
por: Xu, Jun, et al.
Publicado: (2018)

Synthesis and evaluation of a prodrug of 5-aminosalicylic acid for the treatment of ulcerative colitis
por: Yan, Yan, et al.
Publicado: (2019)

Ulcerative Colitis Impairs the Acylethanolamide-Based Anti-Inflammatory System Reversal by 5-Aminosalicylic Acid and Glucocorticoids
por: Suárez, Juan, et al.
Publicado: (2012)

Prolonged Antigen Ingestion by Sensitized Mice Ameliorates Airway Inflammation
por: Noviello, Maria de Lourdes Meirelles, et al.
Publicado: (2011)

Factors associated with low adherence to oral 5-aminosalicylic acid in patients with ulcerative colitis
por: Lee, Jin, et al.
Publicado: (2019)

Colon-targeting mutual prodrugs of 5-aminosalicylic acid and butyrate for the treatment of ulcerative colitis
por: Yan, Yan, et al.
Publicado: (2018)

Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis
por: Park, Soo-Kyung, et al.
Publicado: (2022)

5-Aminosalicylates Reduce the Risk of Colorectal Neoplasia in Patients with Ulcerative Colitis: An Updated Meta-Analysis
por: Zhao, Li-Na, et al.
Publicado: (2014)

5-Aminosalicylic Acid Inhibits Acute Clostridium difficile Toxin A-Induced Colitis in Rats
por: Vigna, Steven R.
Publicado: (2014)

A New Chinese Medicine Intestine Formula Greatly Improves the Effect of Aminosalicylate on Ulcerative Colitis
por: Liu, Baohai, et al.
Publicado: (2017)

Clinical Background Factors as Predictors of the Efficacy of 5-Aminosalicylic Acid Suppositories in Patients with Ulcerative Colitis
por: Uchiyama, Kazuhiko, et al.
Publicado: (2023)

Para-Aminosalicylic Acid: Pas
Publicado: (1950)

Efficacy and safety of Kangfuxin liquid combined with aminosalicylic acid for the treatment of ulcerative colitis: A systematic review and meta-analysis
por: Li, Hui-biao, et al.
Publicado: (2018)

Azathioprine Hypersensitivity Syndrome: Two Cases of Febrile Neutrophilic Dermatosis Induced by Azathioprine
por: Aleissa, Majed, et al.
Publicado: (2017)

Fatal rhinocerebral mucormycosis in a patient with ulcerative colitis receiving azathioprine and corticosteroid
por: Najafi, Narges, et al.
Publicado: (2019)

Posterior Reversible Encephalopathy Syndrome After Azathioprine Administration in Severe Ulcerative Colitis
por: Vernia, Filippo, et al.
Publicado: (2021)

Comparison of maintenance effect of probiotics and aminosalicylates on ulcerative colitis: A meta-analysis of randomized controlled trials
por: Jiang, Yong, et al.
Publicado: (2016)

Mucosal 5‐aminosalicylic acid concentration, drug formulation and mucosal microbiome in patients with quiescent ulcerative colitis
por: Olaisen, Maya, et al.
Publicado: (2019)

Colitis and Crohn’s Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease
por: Sood, Ajit, et al.
Publicado: (2020)

Therapeutic Efficacy of the Combination Therapy of Corticosteroids and 5-Aminosalicylic Acid for Treatment of Pyoderma Gangrenosum with Ulcerative Colitis
por: Chen, Wei, et al.
Publicado: (2020)

Comparison of effects of aminosalicylic acid, glucocorticoids and immunosuppressive agents on the expression of multidrug-resistant genes in ulcerative colitis
por: Chen, Yan, et al.
Publicado: (2022)

Five-Aminosalicylic Acid: An Update for the Reappraisal of an Old Drug
por: Perrotta, Cristiana, et al.
Publicado: (2015)

Para-Aminosalicylic Acid in Pulmonary Tuberculosis
por: Horne, Norman W.
Publicado: (1949)

p-Aminosalicylic Acid (P.A.S.)
por: Spring, F. S.
Publicado: (1949)

Aminosalicylates and COVID-19: Facts or Coincidences?
por: Magro, Fernando, et al.
Publicado: (2021)

Low-dose azathioprine and allopurinol versus azathioprine monotherapy in patients with ulcerative colitis (AAUC): An investigator-initiated, open, multicenter, parallel-arm, randomised controlled trial
por: Kiszka-Kanowitz, Marianne, et al.
Publicado: (2022)

Fecal microbiota transplantation treatment for refractory ulcerative colitis with allergy to 5-aminosalicylic acid: A case report
por: Wang, Hong-Gang, et al.
Publicado: (2018)

Probiotics combined with aminosalicylic acid affiliates remission of ulcerative colitis: a meta-analysis of randomized controlled trial
por: Peng, Lijun, et al.
Publicado: (2019)

5-Aminosalicylic acid intolerance is associated with a risk of adverse clinical outcomes and dysbiosis in patients with ulcerative colitis
por: Mizuno, Shinta, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o3m7ujplr2h1qrto2fqt2ia0ua